WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Spring festival earnings give film market shot in the armAutomotive industry races to meet growing demandSecondhand economy a winApple opens its eighth store in ShanghaiXi Focus: Key Takeaways from Xi's Meetings with Foreign GuestsTech company finds profit in coal wasteSecondhand economy a winDomestic brands make way into drivers' top 10Shopping trend takes retail sector by stormGreen hydrogen, ammonia, ethanol highlighted for nation's carbon reduction
2.2723s , 6495.0703125 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Global Glance news portal